Pick up a lozenge, and you know exactly what you are holding. You have held one before, probably while nursing a cold or fighting a scratchy throat on a flight. It is a familiar object; compact, unassuming, a little medicinal. What Medilab Healthcare Pvt Ltd is doing is taking that familiar object and quietly filling it with something entirely new
Most revolutions announce themselves loudly. This one comes wrapped in a small, round disc that dissolves on your tongue, and it is changing what Indian healthcare looks like from the inside out.
The Pune-based manufacturer has spent years building what is now one of India’s most extensive lozenge portfolios, over 250 formulations across health categories that the format has never traditionally served. Women’s health. Sports nutrition. Heart care. Stress relief. Children’s wellness. The lozenge, in Medilab’s hands, is no longer just a sore throat remedy. It has become a delivery vehicle for daily, preventive, targeted wellness.
And this, the company says, is only the beginning.
A Problem Worth Solving
Compliance, actually taking the supplement consistently, is one of the most stubborn challenges in the wellness industry. Lozenges sidestep most of these objections. They require no water, no preparation, and no convincing yourself that the texture is acceptable. They dissolve at a pace that supports faster mucosal absorption for certain ingredients. They are, frankly, pleasant to consume, which matters more than the clinical literature tends to acknowledge.
Medilab recognised this gap and built its entire product philosophy around it. If the format makes compliance easier, then the next question is simple: what else can we put in it?
“Lozenges are no longer just for cough and throat relief; they are becoming a powerful and convenient platform for everyday wellness and advanced healthcare support.”
First in India. Ready for the World.
The phrase appears in Medilab’s corporate communication as a statement of intent, not marketing copy. What it describes is a concrete market reality: the company has developed India’s first wellness-focused lozenge range spanning nine distinct health categories, each formulated to address real, documented consumer health needs.
Women’s Health Lozenges fill a gap that the Indian supplement market has historically addressed only through tablets and capsules, targeted nutrition for women’s specific physiological requirements, in a format that actually gets taken. Sports Nutrition Lozenges bring performance and recovery support to athletes who want something more convenient than a protein shake or a bulky supplement regimen.
Immunity Support Lozenges combine vitamins, minerals, and herbal extracts in a daily-use format that makes consistency achievable. Digestive Wellness and Energy and Vitality variants address the two most common wellness complaints among working adults. Herbal Wellness Lozenges bring Ayurvedic ingredients into a precision-manufactured modern format. Heart Wellness Lozenges offer cardiovascular support in a form factor that lends itself to daily habit-building. Kids Wellness Lozenges solve perhaps the most underrated problem in paediatric health, getting children to actually consume their supplements willingly. And Stress Relief and Relaxation Lozenges address mental wellness at a moment when that category is finally receiving the commercial and clinical attention it has long deserved.
Nine categories. Over 250 formulations. All developed in-house. All manufactured in a single certified facility.
Where Ayurveda Meets the Lab
Medilab’s formulation approach is not a compromise between tradition and science. It is an integration of both, and the distinction matters.
The company’s Research and Development Centre employs scientists who work across Ayurvedic pharmacognosy and modern nutraceutical science simultaneously. An ingredient like Ashwagandha does not arrive in a Medilab formulation because it is trending. It arrives because its adaptogenic properties have been documented in traditional use for centuries and validated in contemporary clinical research, and because the R&D team has determined that it can be incorporated into a lozenge at effective concentrations without compromising the final product’s stability, taste profile, or shelf life.
This is the kind of rigour that makes the company’s HALAL, GMP, ISO, and HACCP certifications meaningful rather than ornamental. Each certification reflects a manufacturing standard that international markets and regulatory bodies can independently verify. For global buyers, pharmaceutical companies in the Middle East, nutraceutical brands in Europe, and wellness distributors in North America, these certifications are the difference between a promising supplier and a credible long-term manufacturing partner.
The Business Case for Lozenges
Medilab’s story is not only a consumer story. A substantial part of what the company is building is an infrastructure for healthcare brands, pharmaceutical companies, and private-label entrepreneurs who want to enter or expand within the lozenge category.
The contract manufacturing and private-label services Medilab offers are comprehensive. A brand that arrives with a product concept leaves with a finished, packaged, documented product ready for market entry. Formulation development, manufacturing, packaging design, regulatory compliance documentation, the company handles the entire value chain. For international partners in particular, this represents a significant reduction in the time, capital, and complexity typically associated with launching a new health product.
The portfolio depth works in the client’s favour here. A brand that wants to launch across multiple wellness categories, say, an immunity range, a women’s health line, and a kids’ product, can do so through a single manufacturing relationship. Consistency in quality standards across all three products is assured because they emerge from the same facility, the same QC processes, and the same regulatory framework.
“From concept to commercialisation, Medilab Healthcare offers innovative, high-quality lozenge solutions backed by in-house R&D, world-class manufacturing, and over 250 formulations designed for daily wellness and specialised healthcare needs.”
What the Expansion Signals
A company investing in manufacturing expansion is a company with conviction about its own future. Medilab’s announced infrastructure expansion goes well beyond lozenges; it is developing an integrated facility that will support Tablets, Capsules, Powders, Liquids, and Ointments alongside its existing lozenge manufacturing unit.
The expanded setup includes Advanced Granulation Facilities, a dedicated Research and Development Centre, and Quality Control and Quality Assurance laboratories built to international standards. The full suite of dosage forms, Tablets, Capsules, Powders, Liquids, Ointments, and Lozenges, will be housed under a single roof with unified quality management.
The practical implication for B2B partners is significant. A pharmaceutical company or wellness brand that currently manufactures different product formats across multiple vendor relationships could consolidate with Medilab, reducing supply chain complexity and improving quality consistency across its entire product portfolio. For Medilab, the expansion positions it as a full-service Ayurvedic and nutraceutical manufacturing partner rather than a specialist lozenge supplier. The ambition is clear: to become a globally trusted name in Indian healthcare manufacturing.
The Bigger Picture
There is a larger story behind what Medilab is doing, and it is worth naming directly. Indian Ayurveda has global credibility. Turmeric, Ashwagandha, Triphala, Tulsi, these are no longer unfamiliar terms in European health food stores or American wellness supplements. Consumer appetite for natural, plant-based, traditionally grounded health products has grown substantially and shows no signs of plateauing.
What Indian Ayurvedic manufacturers have historically struggled to provide is the manufacturing standardisation and regulatory documentation that global markets require. A traditional preparation may be clinically effective and culturally trusted, but if it cannot pass a GMP audit or produce consistent certificate of analysis results batch over batch, it will not enter a regulated international market.
Medilab is addressing exactly this gap. By combining Ayurvedic ingredient knowledge with ISO-certified, GMP-compliant, HACCP and HALAL-approved manufacturing, the company is producing something that has genuine value in both domestic and global markets: Indian wellness knowledge in a form that the world can buy, trust, and use.
That is the real product. Not just the lozenges, though the lozenges are what make the story vivid. The real product is a manufacturing philosophy that takes traditional Indian health knowledge seriously enough to hold it to the same standards it holds everything else.
Medilab Healthcare is not entering a new market. It is creating one and inviting consumers, healthcare brands, distributors, and global partners to be part of what comes next. Whether you are a health-conscious individual looking for a smarter daily supplement, a brand seeking a manufacturing partner with genuine depth, or an international distributor interested in taking Indian wellness to new markets, the conversation starts the same way: with a small disc that dissolves on your tongue and carries rather more inside it than you might expect.
One lozenge at a time.
About Medilab Healthcare Pvt. Ltd.
Founded and headquartered in Pune, Maharashtra, Medilab Healthcare Pvt. Ltd. is a GMP- and ISO-certified pharmaceutical and Ayurvedic manufacturer specialising in B2B supply, private label manufacturing, and contract production. Its flagship consumer product, Medisils Ayurvedic Throat Lozenges, is distributed across 18 Indian states. The company’s new Cosmetics Manufacturing Division expands its service offering into personal care OEM and export-oriented production.
For more information: Lozenges Manufacturer in India | Herbal & Ayurvedic Lozenges – Medilab | info@medilabhealthcare.com
Disclaimer –
This article is a work of original content created for public relations and informational purposes only. It may be published across multiple digital platforms with the full knowledge and consent of the author/publisher. All images, logos, and referenced names are the property of their respective owners and used here solely for illustrative or informational purposes. Unauthorized reproduction, distribution, or modification of this article without prior written permission from the original publisher is strictly prohibited. Any resemblance to other content is purely coincidental or used under fair use policy with proper attribution.
